229 related articles for article (PubMed ID: 16759163)
1. Present and potential future issues in glioblastoma treatment.
Lefranc F; Sadeghi N; Camby I; Metens T; Dewitte O; Kiss R
Expert Rev Anticancer Ther; 2006 May; 6(5):719-32. PubMed ID: 16759163
[TBL] [Abstract][Full Text] [Related]
2. [Glioblastoma treatment in 2010].
Djedid R; Tomasi O; Haidara A; Rynkowski M; Lefranc F
Rev Med Brux; 2009; 30(5):496-505. PubMed ID: 19998795
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in therapy for glioblastoma.
Clarke J; Butowski N; Chang S
Arch Neurol; 2010 Mar; 67(3):279-83. PubMed ID: 20212224
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategies for inhibiting invasion in glioblastoma.
Drappatz J; Norden AD; Wen PY
Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
[TBL] [Abstract][Full Text] [Related]
5. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.
Lefranc F; Brotchi J; Kiss R
J Clin Oncol; 2005 Apr; 23(10):2411-22. PubMed ID: 15800333
[TBL] [Abstract][Full Text] [Related]
6. [New therapeutic approaches in glioblastomas].
Le Guilloux J; Carpentier AF
Rev Neurol (Paris); 2008; 164(6-7):554-9. PubMed ID: 18565354
[TBL] [Abstract][Full Text] [Related]
7. Management of malignant glioma: steady progress with multimodal approaches.
Ashby LS; Ryken TC
Neurosurg Focus; 2006 Apr; 20(4):E3. PubMed ID: 16709034
[TBL] [Abstract][Full Text] [Related]
8. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
9. The impact of recent data on the optimization of standards of care in newly diagnosed glioblastoma.
Cloughesy T
Semin Oncol; 2011 Dec; 38 Suppl 4():S11-20. PubMed ID: 22078643
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for recurrent glioblastoma: pitfalls and future trends.
Franceschi E; Tosoni A; Bartolini S; Mazzocchi V; Fioravanti A; Brandes AA
Expert Rev Anticancer Ther; 2009 May; 9(5):613-9. PubMed ID: 19445578
[TBL] [Abstract][Full Text] [Related]
11. Comparative follow-up of enhancement phenomena with MRI and Proton MR Spectroscopic Imaging after intralesional immunotherapy in glioblastoma--Report of two exceptional cases.
Floeth FW; Wittsack HJ; Engelbrecht V; Weber F
Zentralbl Neurochir; 2002; 63(1):23-8. PubMed ID: 12098080
[TBL] [Abstract][Full Text] [Related]
12. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.
Quant EC; Wen PY
Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556
[TBL] [Abstract][Full Text] [Related]
13. The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas.
Sanghera P; Rampling R; Haylock B; Jefferies S; McBain C; Rees JH; Soh C; Whittle IR
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):216-27. PubMed ID: 21783349
[TBL] [Abstract][Full Text] [Related]
14. New chemotherapy options for the treatment of malignant gliomas.
Soffietti R; Rudà R; Trevisan E
Anticancer Drugs; 2007 Jul; 18(6):621-32. PubMed ID: 17762390
[TBL] [Abstract][Full Text] [Related]
15. Novel therapies for malignant gliomas.
Cavaliere R; Wen PY; Schiff D
Neurol Clin; 2007 Nov; 25(4):1141-71, x. PubMed ID: 17964029
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy.
Blumenthal DT; Schulman SF
Expert Rev Neurother; 2005 Sep; 5(5):683-90. PubMed ID: 16162092
[TBL] [Abstract][Full Text] [Related]
17. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Lefranc F; Rynkowski M; DeWitte O; Kiss R
Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
[TBL] [Abstract][Full Text] [Related]
18. [New therapeutic options in therapy of glioblastoma multiforme].
Lakomý R; Burkon P; Burkonová D; Jancálek R
Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma multiforme: evidence-based approach to therapy.
Nicholas MK
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
